These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34617985)

  • 1. Impact of latent tuberculosis treatment on the risk of mycobacterium tuberculosis (MTB) in seropositive rheumatoid arthritis initiating TNF inhibitors in an MTB endemic area.
    Park DW; Kim YJ; Sung YK; Chung SJ; Yeo Y; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Sohn JW
    Rheumatology (Oxford); 2021 Dec; 60(12):5872-5874. PubMed ID: 34617985
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    Kumar SK; Arya S; Singh A; Misra R; Aggarwal A; Sinha S
    PLoS One; 2021; 16(8):e0255639. PubMed ID: 34339423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients.
    Silva BD; Tannus-Silva DG; Rabahi MF; Kipnis A; Junqueira-Kipnis AP
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):29-37. PubMed ID: 24626307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.
    Park DW; Kim YJ; Sung YK; Chung SJ; Yeo Y; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Sohn JW
    Sci Rep; 2022 Mar; 12(1):4003. PubMed ID: 35256729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the level of IFN-γ produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting.
    Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F
    Int Immunol; 2012 Feb; 24(2):71-8. PubMed ID: 22298884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.
    Marques CD; Duarte ÂL; de Lorena VM; Souza JR; Souza WV; Gomes Yde M; de Carvalho EM
    Rheumatol Int; 2009 Nov; 30(1):57-62. PubMed ID: 19363612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study.
    Song YJ; Cho SK; Kim H; Kim HW; Nam E; Bae SC; Yoo DH; Sung YK
    J Korean Med Sci; 2021 Mar; 36(10):e70. PubMed ID: 33724737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors.
    Lai EC; Liang HY; Huang YC; Huang WI; Chao PH; Chen WW; Weng MY
    Sci Rep; 2021 Sep; 11(1):18013. PubMed ID: 34504225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
    Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
    Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
    J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection.
    Maeda T; Banno S; Maeda S; Naniwa T; Hayami Y; Watanabe M; Itoh R; Sato S; Ueda R
    Mod Rheumatol; 2010 Feb; 20(1):18-23. PubMed ID: 19779763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
    Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
    Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
    Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
    J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of latent tuberculosis infection in a low endemic country.
    de Paus RA; van Meijgaarden KE; Prins C; Kamphorst MH; Arend SM; Ottenhoff THM; Joosten SA
    Tuberculosis (Edinb); 2017 Sep; 106():62-72. PubMed ID: 28802407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.
    Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM
    Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.